The Cardiovascular Medicine Department of Hebei Medical University was established in June 2002, and the Department of Cardiology of Dongyuan hospital was added in September 2012. At present, there are 69 beds, 48 beds in the Department and 21 beds in the east hospital. There are 2 CCU wards and 14 beds. There are 62 medical staff, 22 doctors and 40 nurses, including 4 professors and chief doctors, 6 associate professors and deputy chief doctors, 8 attending doctors, 4 residents and 2 deputy chief nurses. There are 4 tutors for master's degree students, and many excellent graduate students are cultivated every year.
The general practitioners are united and cooperative, and their business is superb. It has special advantages in acute myocardial infarction, heart failure, cardiomyopathy, arrhythmia, etc. In 1961, cardiac catheterization was carried out; in 1971, artificial pacemaker placement and endocardial biopsy were carried out; in the second half of 1988, the U.S. ECG central monitoring station and bedside extension were equipped, and CCU ward was built; in 2002, coronary angiography, PTCA and intracoronary stent implantation were carried out; at present, emergency intervention, CTO, radiofrequency ablation and permanent pacing have been carried out skillfully Device implantation and other technologies. At the same time, combined with the General Hospital of our hospital, which is characterized by tumor treatment, our department is particularly prominent in the diagnosis and treatment of tumor heart disease. In addition, our department now has Philips ECG central monitoring and bedside extension, central monitoring and telemetry monitoring, dynamic blood pressure, exercise tablet and other advanced medical equipment. Every year, we will complete the diagnosis and treatment of common cardiovascular diseases and critical diseases, and actively carry out scientific research. In the past five years, he has published more than 30 academic papers, including 6 SCI papers, more than 10 core journals, won one third prize of Hebei Provincial Science and technology progress, three first prizes of Hebei Medical Science and technology award, one second prize of Hebei Medical Science and technology award, and one person participated in a national science and nature fund project.
Disease scope: coronary heart disease, cardiomyopathy, rheumatic heart disease and valvular disease, various arrhythmias, heart failure, hypertension, pulmonary embolism, deep vein thrombosis, arteriosclerosis, hyperlipidemia, tumor heart disease, etc.